Ethics approval and consent to participate
INS
The study was approved by the independent ethics committee (IEC) Transitory National Committee of Ethics in Research (CNTEI, acronym in Spanish) from Peru, as process number CNTEI-003-200. This trial was conducted in compliance with the International Conference on Harmonisation (ICH-GCP) E6 on Good Clinical Practice and the clinical trial regulations for COVID-19 (Supreme Decree No. 014-2020 SA) from the National Health Institute (INS, acronym in Spanish). All participants gave written informed consent.